Novel 25-hydroxyprotopanaxadiol derivatives incorporating chloroacetyl chloride and their anti-tumor evaluation

被引:26
作者
Qu, Fan-Zhi
Liu, Ya-Fei
Cao, Jia-Qing
Wang, Xu-De
Zhang, Xiao-Shu
Zhao, Chen
Zhao, Yu-Qing [1 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Tradit Chinese Med, Shenyang 110016, Peoples R China
基金
美国国家科学基金会;
关键词
Chloroacetyl chloride; 25-OH-PPD; Derivatives; Anti-tumor activity; MTT; GINSENG PROTOPANAXADIOL SAPONINS; INTESTINAL BACTERIA; ANTICANCER ACTIVITY; NATURAL-PRODUCT; RAT PLASMA; 20(S)-25-METHOXYL-DAMMARANE-3-BETA; PHARMACOKINETICS; TRANSFORMATION; PHARMACOLOGY; METABOLITE;
D O I
10.1016/j.bmcl.2014.10.050
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
In the current work, 12 novel 25-hydroxyprotopanaxadiol (25-OH-PPD) derivatives were synthesized by reacting with chloroacetyl chloride. And their in vitro antitumor activities were evaluated on six human tumor cell lines by MTT assay. The results demonstrated that, as compared with 25-OH-PPD, compounds 4, 6 and 7 exhibited higher cytotoxic activity on all tested cell lines. Of them, compound 4 showed strongly inhibition against MCF-7, HCT-116 and Lovo cells with IC50 values of 1.7, 1.6 and 2.1 mu M, respectively. The IC50 values of compound 6 against HCT-116 and 7 against MCF-7 were the lowest (1.2 and 1.6 mu M, respectively). It was also noted that compound 4 showed a 20- to 100-fold greater growth inhibition than ginsenoside-Rg(3) (an anti-cancer regular drug in China). In conclusion, the data revealed that compounds 4, 6 and 7 were potential candidates for anti-tumor treatment and may be useful for the development of novel antiproliferative agents. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5390 / 5394
页数:5
相关论文
共 29 条
[1]
Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng [J].
Akao, T ;
Kida, H ;
Kanaoka, M ;
Hattori, M ;
Kobashi, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (10) :1155-1160
[2]
Ginseng pharmacology - Multiple constituents and multiple actions [J].
Attele, AS ;
Wu, JA ;
Yuan, CS .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (11) :1685-1693
[3]
Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants [J].
Bae, EA ;
Han, MJ ;
Kim, EJ ;
Kim, DH .
ARCHIVES OF PHARMACAL RESEARCH, 2004, 27 (01) :61-67
[4]
Panax ginseng - A systematic review of adverse effects and drug interactions [J].
Coon, JT ;
Ernst, E .
DRUG SAFETY, 2002, 25 (05) :323-344
[5]
Superior anticancer activity of halogenated chalcones and flavonols over the natural flavonol quercetin [J].
Dias, Tatiana A. ;
Duarte, Cecilia L. ;
Lima, Cristovao F. ;
Fernanda Proenca, M. ;
Pereira-Wilson, Cristina .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 65 :500-510
[6]
Panax ginseng pharmacology: A nitric oxide link? [J].
Gillis, CN .
BIOCHEMICAL PHARMACOLOGY, 1997, 54 (01) :1-8
[7]
Pharmacokinetics and tissue distribution of 25-hydroxyprotopanaxadiol, an anti-cancer compound isolated from Panax ginseng, in athymic mice bearing xenografts of human pancreatic tumors [J].
Hao, Miao ;
Wang, Wei ;
Zhao, Yuqing ;
Zhang, Ruiwen ;
Wang, Hui .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2011, 35 (3-4) :109-113
[8]
Proof of the mysterious efficacy of ginseng: Basic and clinical trials: Metabolic activation of ginsenoside: Deglycosylation by intestinal bacteria and esterification with fatty acid [J].
Hasegawa, H .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 95 (02) :153-157
[9]
Prevention of growth and metastasis of murine melanoma through enhanced natural-killer cytotoxicity by fatty acid-conjugate of protopanaxatriol [J].
Hasegawa, H ;
Suzuki, R ;
Nagaoka, T ;
Tezuka, Y ;
Kadota, S ;
Saiki, I .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (07) :861-866
[10]
Hasegawa H, 2000, BIOL PHARM BULL, V23, P298, DOI 10.1248/bpb.23.298